| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Organoids | 19 | 2024 | 281 | 4.580 |
Why?
|
| Rotavirus Infections | 20 | 2025 | 354 | 4.400 |
Why?
|
| Intestinal Mucosa | 18 | 2024 | 778 | 2.800 |
Why?
|
| Rotavirus | 18 | 2025 | 497 | 2.770 |
Why?
|
| Intestines | 14 | 2024 | 577 | 2.210 |
Why?
|
| Intestine, Small | 9 | 2024 | 309 | 1.660 |
Why?
|
| Stem Cells | 10 | 2023 | 709 | 1.270 |
Why?
|
| B-Lymphocytes | 6 | 2025 | 532 | 1.210 |
Why?
|
| Lymphocyte Activation | 3 | 2025 | 700 | 1.160 |
Why?
|
| Host-Pathogen Interactions | 5 | 2021 | 253 | 1.070 |
Why?
|
| Gastrointestinal Diseases | 5 | 2021 | 338 | 0.910 |
Why?
|
| Intestinal Diseases | 3 | 2019 | 83 | 0.910 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2025 | 85 | 0.900 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 288 | 0.890 |
Why?
|
| Intestinal Polyposis | 1 | 2023 | 17 | 0.860 |
Why?
|
| Antigens, Viral | 6 | 2011 | 439 | 0.800 |
Why?
|
| Dendritic Cells | 1 | 2025 | 414 | 0.780 |
Why?
|
| Cell Differentiation | 5 | 2024 | 1908 | 0.750 |
Why?
|
| Adult Stem Cells | 2 | 2019 | 54 | 0.740 |
Why?
|
| Immunoglobulin A | 3 | 2025 | 207 | 0.690 |
Why?
|
| Cell Culture Techniques | 6 | 2021 | 276 | 0.680 |
Why?
|
| Virus Replication | 8 | 2024 | 607 | 0.640 |
Why?
|
| Communicable Diseases | 1 | 2021 | 161 | 0.630 |
Why?
|
| Microinjections | 1 | 2018 | 52 | 0.600 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 576 | 0.570 |
Why?
|
| Virion | 3 | 2008 | 147 | 0.560 |
Why?
|
| Microchip Analytical Procedures | 1 | 2017 | 6 | 0.560 |
Why?
|
| Norovirus | 5 | 2024 | 317 | 0.560 |
Why?
|
| Microfluidics | 1 | 2017 | 22 | 0.550 |
Why?
|
| Regeneration | 1 | 2019 | 211 | 0.550 |
Why?
|
| Calcitriol | 5 | 2021 | 80 | 0.540 |
Why?
|
| Viremia | 3 | 2007 | 129 | 0.520 |
Why?
|
| Antibodies, Viral | 8 | 2013 | 1153 | 0.480 |
Why?
|
| Mice | 26 | 2025 | 17744 | 0.460 |
Why?
|
| Caliciviridae Infections | 5 | 2024 | 328 | 0.440 |
Why?
|
| Animals | 33 | 2025 | 34309 | 0.430 |
Why?
|
| Models, Biological | 5 | 2020 | 1466 | 0.430 |
Why?
|
| Mice, Inbred C57BL | 9 | 2025 | 4420 | 0.430 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2020 | 698 | 0.420 |
Why?
|
| IgA Deficiency | 1 | 2012 | 5 | 0.400 |
Why?
|
| Tissue Engineering | 3 | 2020 | 173 | 0.390 |
Why?
|
| Space Flight | 2 | 2022 | 107 | 0.380 |
Why?
|
| Cells, Cultured | 5 | 2021 | 3043 | 0.360 |
Why?
|
| Immunity, Innate | 5 | 2024 | 372 | 0.360 |
Why?
|
| Escherichia coli Infections | 3 | 2021 | 189 | 0.350 |
Why?
|
| Virus Cultivation | 3 | 2024 | 76 | 0.340 |
Why?
|
| Respiratory Syncytial Virus, Human | 2 | 2024 | 207 | 0.340 |
Why?
|
| Transcriptome | 5 | 2024 | 977 | 0.340 |
Why?
|
| Organ Culture Techniques | 4 | 2018 | 154 | 0.320 |
Why?
|
| Telomere | 2 | 2021 | 220 | 0.320 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2024 | 345 | 0.320 |
Why?
|
| Humans | 45 | 2024 | 125438 | 0.310 |
Why?
|
| Bacterial Adhesion | 2 | 2020 | 105 | 0.310 |
Why?
|
| Peyer's Patches | 2 | 2025 | 21 | 0.300 |
Why?
|
| Rotavirus Vaccines | 2 | 2006 | 72 | 0.300 |
Why?
|
| Prostatic Neoplasms | 5 | 2001 | 1549 | 0.290 |
Why?
|
| Interferons | 2 | 2020 | 126 | 0.290 |
Why?
|
| Mice, Inbred BALB C | 6 | 2012 | 1001 | 0.280 |
Why?
|
| Colon | 3 | 2021 | 352 | 0.280 |
Why?
|
| Culture Media | 3 | 2024 | 181 | 0.270 |
Why?
|
| Capsid Proteins | 2 | 2005 | 184 | 0.270 |
Why?
|
| RNA, Viral | 2 | 2006 | 538 | 0.260 |
Why?
|
| Enterocytes | 5 | 2024 | 74 | 0.260 |
Why?
|
| CD11c Antigen | 1 | 2025 | 38 | 0.240 |
Why?
|
| Mucin-2 | 1 | 2024 | 41 | 0.230 |
Why?
|
| Disease Resistance | 1 | 2024 | 23 | 0.230 |
Why?
|
| Diarrhea | 3 | 2021 | 317 | 0.230 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2024 | 84 | 0.230 |
Why?
|
| Gastroenteritis | 4 | 2024 | 348 | 0.230 |
Why?
|
| Nasal Mucosa | 1 | 2024 | 66 | 0.220 |
Why?
|
| Sequence Analysis, RNA | 3 | 2021 | 371 | 0.220 |
Why?
|
| Nutritional Status | 2 | 2012 | 316 | 0.220 |
Why?
|
| Weightlessness | 1 | 2004 | 46 | 0.210 |
Why?
|
| Viruses | 2 | 2021 | 122 | 0.210 |
Why?
|
| Immunity | 1 | 2004 | 192 | 0.200 |
Why?
|
| Cosmic Radiation | 1 | 2022 | 11 | 0.200 |
Why?
|
| Serotonin | 1 | 2023 | 217 | 0.200 |
Why?
|
| T-Lymphocytes | 3 | 2011 | 1720 | 0.200 |
Why?
|
| Radiation Protection | 1 | 2022 | 54 | 0.190 |
Why?
|
| Liver | 2 | 2021 | 1749 | 0.190 |
Why?
|
| Radiation Exposure | 1 | 2022 | 42 | 0.190 |
Why?
|
| Gastrointestinal Tract | 2 | 2021 | 213 | 0.190 |
Why?
|
| Enterohepatic Circulation | 1 | 2021 | 10 | 0.190 |
Why?
|
| Wnt Signaling Pathway | 1 | 2023 | 193 | 0.180 |
Why?
|
| Enteropathogenic Escherichia coli | 1 | 2021 | 6 | 0.180 |
Why?
|
| Epithelial Cells | 3 | 2024 | 909 | 0.180 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2020 | 17 | 0.170 |
Why?
|
| Hydrogels | 1 | 2021 | 83 | 0.170 |
Why?
|
| Gluconeogenesis | 1 | 2020 | 106 | 0.170 |
Why?
|
| Cytokines | 2 | 2024 | 1288 | 0.170 |
Why?
|
| Endometrium | 1 | 2023 | 280 | 0.170 |
Why?
|
| Escherichia coli | 3 | 2021 | 984 | 0.160 |
Why?
|
| Probiotics | 2 | 2012 | 214 | 0.160 |
Why?
|
| Virus Diseases | 2 | 2021 | 280 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 172 | 0.160 |
Why?
|
| Stomach | 1 | 2021 | 270 | 0.160 |
Why?
|
| Ileum | 1 | 2019 | 133 | 0.150 |
Why?
|
| Uterus | 1 | 2023 | 567 | 0.150 |
Why?
|
| Computers | 1 | 2018 | 68 | 0.150 |
Why?
|
| Obesity, Morbid | 1 | 2020 | 185 | 0.150 |
Why?
|
| Virus Physiological Phenomena | 1 | 2018 | 14 | 0.150 |
Why?
|
| Tissue Culture Techniques | 2 | 2018 | 67 | 0.150 |
Why?
|
| Escherichia coli Proteins | 1 | 2020 | 304 | 0.150 |
Why?
|
| Viral Tropism | 1 | 2018 | 43 | 0.140 |
Why?
|
| Vitamin D | 1 | 1999 | 165 | 0.140 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 1756 | 0.140 |
Why?
|
| Immunity, Mucosal | 2 | 2019 | 87 | 0.140 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2021 | 303 | 0.140 |
Why?
|
| Cell Proliferation | 3 | 2023 | 2372 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 560 | 0.130 |
Why?
|
| G1 Phase | 1 | 1997 | 67 | 0.130 |
Why?
|
| Tretinoin | 1 | 1997 | 118 | 0.130 |
Why?
|
| Feces | 3 | 2021 | 727 | 0.130 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 664 | 0.130 |
Why?
|
| Apoptosis | 2 | 2000 | 1817 | 0.130 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2017 | 107 | 0.130 |
Why?
|
| Glucose | 1 | 2020 | 878 | 0.130 |
Why?
|
| Blood-Brain Barrier | 1 | 2017 | 143 | 0.130 |
Why?
|
| Bacteria | 1 | 2019 | 481 | 0.130 |
Why?
|
| Antigens, Differentiation | 1 | 2015 | 62 | 0.120 |
Why?
|
| Signal Transduction | 2 | 2025 | 4595 | 0.120 |
Why?
|
| Species Specificity | 2 | 2006 | 551 | 0.120 |
Why?
|
| Mice, Knockout | 3 | 2024 | 3753 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 4 | 2001 | 1077 | 0.110 |
Why?
|
| Prostate | 1 | 1997 | 436 | 0.110 |
Why?
|
| Antineoplastic Agents | 2 | 2001 | 1714 | 0.110 |
Why?
|
| Models, Theoretical | 1 | 2015 | 364 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 296 | 0.100 |
Why?
|
| Inflammation | 1 | 2020 | 1447 | 0.100 |
Why?
|
| Lymphotoxin-alpha | 1 | 2012 | 8 | 0.100 |
Why?
|
| Female | 12 | 2024 | 66887 | 0.100 |
Why?
|
| Infant | 5 | 2024 | 12597 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2000 | 1980 | 0.100 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 216 | 0.090 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 89 | 0.090 |
Why?
|
| Animals, Newborn | 2 | 2012 | 1018 | 0.090 |
Why?
|
| Male | 13 | 2024 | 61626 | 0.090 |
Why?
|
| Phenotype | 1 | 2020 | 4269 | 0.090 |
Why?
|
| Interleukin-18 | 2 | 2021 | 61 | 0.090 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 2 | 2021 | 100 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 945 | 0.090 |
Why?
|
| Viral Load | 1 | 2012 | 388 | 0.080 |
Why?
|
| Telomerase | 2 | 2021 | 169 | 0.080 |
Why?
|
| Body Weight | 2 | 2012 | 989 | 0.080 |
Why?
|
| Adhesins, Escherichia coli | 2 | 2020 | 20 | 0.080 |
Why?
|
| Gene Deletion | 1 | 2012 | 793 | 0.080 |
Why?
|
| Cell Division | 3 | 2001 | 780 | 0.080 |
Why?
|
| Cell Movement | 1 | 2012 | 854 | 0.070 |
Why?
|
| Calcium | 3 | 2007 | 1105 | 0.070 |
Why?
|
| Gene Expression | 1 | 2012 | 1554 | 0.070 |
Why?
|
| Cell Cycle | 2 | 2000 | 627 | 0.070 |
Why?
|
| HT29 Cells | 1 | 2007 | 44 | 0.070 |
Why?
|
| Diarrhea, Infantile | 1 | 2007 | 35 | 0.070 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2007 | 3 | 0.070 |
Why?
|
| Organ Specificity | 2 | 2018 | 426 | 0.070 |
Why?
|
| Immunoassay | 1 | 2007 | 130 | 0.070 |
Why?
|
| Neoplasms | 1 | 2021 | 2800 | 0.070 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2007 | 131 | 0.060 |
Why?
|
| Toxins, Biological | 1 | 2007 | 69 | 0.060 |
Why?
|
| Intussusception | 1 | 2006 | 48 | 0.060 |
Why?
|
| Cell Line | 3 | 2019 | 2755 | 0.060 |
Why?
|
| Administration, Intranasal | 1 | 2005 | 132 | 0.060 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2007 | 190 | 0.060 |
Why?
|
| Paneth Cells | 1 | 2024 | 23 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 2006 | 297 | 0.060 |
Why?
|
| Animals, Outbred Strains | 1 | 2004 | 12 | 0.060 |
Why?
|
| Actins | 1 | 2007 | 345 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2007 | 367 | 0.060 |
Why?
|
| Hindlimb Suspension | 1 | 2004 | 11 | 0.060 |
Why?
|
| Child | 4 | 2020 | 24606 | 0.060 |
Why?
|
| Rodent Diseases | 1 | 2003 | 17 | 0.050 |
Why?
|
| Goblet Cells | 1 | 2024 | 103 | 0.050 |
Why?
|
| Cattle Diseases | 1 | 2003 | 21 | 0.050 |
Why?
|
| Jejunum | 1 | 2024 | 127 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2005 | 682 | 0.050 |
Why?
|
| Antigens, CD | 2 | 2002 | 430 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2004 | 266 | 0.050 |
Why?
|
| Adult | 4 | 2024 | 29635 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2024 | 299 | 0.050 |
Why?
|
| Moon | 1 | 2022 | 11 | 0.050 |
Why?
|
| Rabbits | 1 | 2003 | 717 | 0.050 |
Why?
|
| Stem Cell Niche | 1 | 2023 | 56 | 0.050 |
Why?
|
| Immunologic Memory | 1 | 2004 | 190 | 0.050 |
Why?
|
| GTPase-Activating Proteins | 1 | 2023 | 87 | 0.050 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2002 | 38 | 0.050 |
Why?
|
| Cattle | 1 | 2003 | 567 | 0.050 |
Why?
|
| Lymphoid Tissue | 1 | 2002 | 46 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2024 | 395 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2002 | 71 | 0.050 |
Why?
|
| Mice, Nude | 2 | 2001 | 725 | 0.050 |
Why?
|
| Epithelium | 1 | 2023 | 365 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2002 | 200 | 0.050 |
Why?
|
| Sex Factors | 1 | 2005 | 1282 | 0.050 |
Why?
|
| Ketones | 1 | 2001 | 26 | 0.050 |
Why?
|
| Biphenyl Compounds | 1 | 2001 | 62 | 0.050 |
Why?
|
| Integrins | 1 | 2002 | 97 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2002 | 212 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2019 | 682 | 0.050 |
Why?
|
| Laminin | 1 | 2021 | 69 | 0.050 |
Why?
|
| Proteoglycans | 1 | 2021 | 88 | 0.050 |
Why?
|
| Receptors, Calcitriol | 1 | 2001 | 70 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2020 | 1638 | 0.050 |
Why?
|
| Rats | 3 | 2003 | 3727 | 0.050 |
Why?
|
| Glucose Transporter Type 5 | 1 | 2020 | 5 | 0.040 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2020 | 8 | 0.040 |
Why?
|
| Sodium-Glucose Transporter 1 | 1 | 2020 | 11 | 0.040 |
Why?
|
| Palivizumab | 1 | 2021 | 47 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 1293 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2021 | 265 | 0.040 |
Why?
|
| Fimbriae, Bacterial | 1 | 2020 | 42 | 0.040 |
Why?
|
| Caspase 1 | 1 | 2020 | 43 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2012 | 4406 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 238 | 0.040 |
Why?
|
| Biocompatible Materials | 1 | 2021 | 117 | 0.040 |
Why?
|
| Collagen | 1 | 2021 | 317 | 0.040 |
Why?
|
| Estrogens | 1 | 2023 | 505 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2000 | 12 | 0.040 |
Why?
|
| Dietary Carbohydrates | 1 | 2020 | 119 | 0.040 |
Why?
|
| Intestinal Absorption | 1 | 2020 | 190 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 2000 | 56 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2020 | 151 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2020 | 385 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2000 | 127 | 0.040 |
Why?
|
| Ki-67 Antigen | 1 | 2000 | 114 | 0.040 |
Why?
|
| Enteroendocrine Cells | 1 | 2019 | 21 | 0.040 |
Why?
|
| Hypercalcemia | 1 | 1999 | 40 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 240 | 0.040 |
Why?
|
| Virulence Factors | 1 | 2020 | 173 | 0.040 |
Why?
|
| RANK Ligand | 1 | 2019 | 52 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 294 | 0.040 |
Why?
|
| Bariatric Surgery | 1 | 2020 | 120 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2002 | 480 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2021 | 279 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 256 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2000 | 691 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2000 | 1109 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2000 | 802 | 0.030 |
Why?
|
| Retinoid X Receptors | 1 | 1997 | 33 | 0.030 |
Why?
|
| Terfenadine | 1 | 2017 | 2 | 0.030 |
Why?
|
| Methylamines | 1 | 2017 | 19 | 0.030 |
Why?
|
| Cholecalciferol | 1 | 2017 | 24 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 1997 | 100 | 0.030 |
Why?
|
| Drug Synergism | 1 | 1997 | 227 | 0.030 |
Why?
|
| Bile | 1 | 2016 | 46 | 0.030 |
Why?
|
| Ligands | 1 | 2018 | 538 | 0.030 |
Why?
|
| Biological Transport | 1 | 2017 | 355 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2000 | 681 | 0.030 |
Why?
|
| Metabolome | 1 | 2017 | 292 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 155 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 193 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2013 | 118 | 0.030 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 1993 | 11 | 0.030 |
Why?
|
| Lymphocyte Depletion | 1 | 2013 | 121 | 0.030 |
Why?
|
| Lung | 1 | 2021 | 1487 | 0.030 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1993 | 80 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 2524 | 0.030 |
Why?
|
| Virus Shedding | 1 | 2012 | 81 | 0.020 |
Why?
|
| Plasma Cells | 1 | 2012 | 53 | 0.020 |
Why?
|
| Leukocytes | 1 | 2013 | 212 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2012 | 309 | 0.020 |
Why?
|
| Thinness | 1 | 2012 | 71 | 0.020 |
Why?
|
| Hypothalamus | 1 | 1993 | 214 | 0.020 |
Why?
|
| Metagenome | 1 | 2012 | 148 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 360 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2024 | 8268 | 0.020 |
Why?
|
| Antibodies | 1 | 2012 | 374 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 245 | 0.020 |
Why?
|
| DNA Primers | 1 | 2012 | 657 | 0.020 |
Why?
|
| Base Sequence | 2 | 2012 | 3109 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 1997 | 1284 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 1271 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2006 | 14142 | 0.020 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2012 | 363 | 0.020 |
Why?
|
| Phylogeny | 1 | 2012 | 687 | 0.020 |
Why?
|
| Pregnancy | 1 | 2023 | 7222 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2011 | 586 | 0.020 |
Why?
|
| Overweight | 1 | 2012 | 363 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1993 | 1587 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 2429 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 1997 | 2061 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1703 | 0.020 |
Why?
|
| Transcription Factors | 1 | 1997 | 2603 | 0.020 |
Why?
|
| Gastrointestinal Transit | 1 | 2006 | 22 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 1993 | 2812 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2007 | 381 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2003 | 16362 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 824 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2006 | 505 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1692 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 6324 | 0.010 |
Why?
|
| Receptors, Collagen | 1 | 2002 | 7 | 0.010 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2002 | 20 | 0.010 |
Why?
|
| Integrin alpha2 | 1 | 2002 | 9 | 0.010 |
Why?
|
| Sialic Acids | 1 | 2002 | 20 | 0.010 |
Why?
|
| Integrin beta1 | 1 | 2002 | 56 | 0.010 |
Why?
|
| Integrin alpha4beta1 | 1 | 2002 | 37 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2001 | 38 | 0.010 |
Why?
|
| Neuraminidase | 1 | 2002 | 36 | 0.010 |
Why?
|
| CHO Cells | 1 | 2002 | 169 | 0.010 |
Why?
|
| Cricetinae | 1 | 2002 | 422 | 0.010 |
Why?
|
| Random Allocation | 1 | 2001 | 439 | 0.010 |
Why?
|
| Transfection | 1 | 2002 | 1076 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2001 | 914 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 1026 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1993 | 46 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1993 | 1242 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1993 | 3897 | 0.000 |
Why?
|